Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. A drug taken ...
A new study reveals rapamycin may undermine exercise benefits, challenging its hype as a longevity breakthrough.
Hosted on MSN
Fighting cancer cachexia with nutrition and care
Cancer cachexia robs patients of weight, muscle, and strength, undermining treatment success and quality of life. Experts now advocate for a multimodal approach—combining nutrition, exercise, and ...
Kerstin Haase is in the Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK. Mariam Jamal-Hanjani is in the Cancer Research UK Lung ...
MUNICH--(BUSINESS WIRE)--CatalYm today announced new findings from its ongoing Phase 1/2a study as well as preclinical research, highlighting the therapeutic potential of its lead drug candidate, ...
A large-scale, 5-year clinical trial from the Generation 100 study in Norway has found that high-intensity interval training ...
Ponsegromab treatment led to sustained weight gain and GDF-15 suppression over 64 weeks in cancer-associated cachexia patients. Patients initially on placebo gained weight after switching to ...
Hosted on MSN
Cancer cell study sheds light on cachexia's origins
New research from the University of Oklahoma, published today in Cancer Cell, describes for the first time a "triangle regulation theory" of cancer-induced cachexia and anorexia. Cachexia is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results